Generation of three induced pluripotent stem cell lines (UQACi003-A, UQACi004-A, and UQACi006-A) from three patients with KRT5 epidermolysis bullosa simplex mutations

Stem Cell Res. 2022 Apr:60:102726. doi: 10.1016/j.scr.2022.102726. Epub 2022 Feb 25.

Abstract

Heterozygous mutations within Keratin 5 (KRT5) are common genetic causes of epidermolysis bullosa simplex (EBS), a skin fragility disorder characterized by blisters, which appear after minor trauma. Using CytoTune®Sendai virus, we generated three human induced pluripotent stem cell (iPSC) lines from three EBS patients carrying respectively the single heterozygous mutations in KRT5, c.449 T > C, c.980 T > C, and c.608 T > C. All lines display normal karyotype, expressed high levels of pluripotent markers, and can differentiate into derivatives of the three germ layers. These iPSCs are helpful for a better understanding of the EBS pathogenesis and developing novel therapeutic approaches.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epidermolysis Bullosa Simplex* / genetics
  • Epidermolysis Bullosa Simplex* / pathology
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Keratin-5 / genetics
  • Mutation / genetics

Substances

  • KRT5 protein, human
  • Keratin-5